Marcel Stoeckle Selected Research

Leishmaniasis

10/2013	Treatment of mucosal leishmaniasis (L. infantum) with miltefosine in a patient with Good syndrome.
3/2012	Successful treatment of imported mucosal Leishmania infantum leishmaniasis with miltefosine after severe hypokalemia under meglumine antimoniate treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcel Stoeckle Research Topics

Disease

5	Infections 01/2021 - 01/2015
5	COVID-19 01/2021 - 01/2020
3	HIV Infections (HIV Infection) 12/2019 - 01/2015
2	Leishmaniasis 10/2013 - 03/2012
1	Spontaneous Abortion (Miscarriage) 01/2022
1	Inflammation (Inflammations) 01/2020
1	Chronic Disease (Chronic Diseases) 12/2019
1	Viremia 10/2019
1	Yellow Fever 01/2018
1	Disease Progression 01/2017
1	Dementia (Dementias) 01/2017
1	Esophagitis 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2015
1	Neoplasms (Cancer) 03/2015
1	Second Primary Neoplasms (Neoplasms, Second) 03/2015
1	Hodgkin Disease (Hodgkin's Disease) 03/2015
1	Chronic Hepatitis C 01/2015
1	Venous Thromboembolism 01/2014
1	Hemorrhage 01/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2014
1	Opportunistic Infections (Opportunistic Infection) 01/2014
1	Cutaneous Leishmaniasis 10/2013
1	Erectile Dysfunction 01/2013
1	Hypokalemia 03/2012
1	Obesity 01/2012
1	Pruritus (Itching) 01/2010

Drug/Important Bio-Agent (IBA)

4	Lopinavir FDA Link 01/2021 - 01/2020
4	Pharmaceutical PreparationsIBA 10/2020 - 03/2015
4	RNA (Ribonucleic Acid)IBA 01/2018 - 07/2015
2	Ritonavir (Norvir)FDA Link 11/2020 - 10/2020
2	etravirine (TMC-125)FDA Link 07/2015 - 03/2015
2	Protease Inhibitors (Protease Inhibitor)IBA 07/2015 - 03/2015
2	miltefosine (Impavido)IBA 10/2013 - 03/2012
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Immunoglobulin G (IgG)IBA 11/2020
1	EnzymesIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	CytokinesIBA 01/2020
1	Cytochrome P-450 CYP3AIBA 01/2020
1	dolutegravirIBA 10/2019
1	lamivudine drug combination abacavir FDA Link 10/2019
1	Antiviral Agents (Antivirals)IBA 07/2018
1	Tenofovir (Viread)FDA Link 01/2017
1	Rilpivirine (TMC-278)IBA 01/2017
1	Emtricitabine (Emtriva)FDA Link 01/2017
1	TabletsIBA 01/2017
1	tenofovir alafenamideIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2015
1	efavirenz (Sustiva)FDA Link 07/2015
1	LipidsIBA 07/2015
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 03/2015
1	Antineoplastic Agents (Antineoplastics)IBA 03/2015
1	InterferonsIBA 01/2015
1	Ribavirin (Virazole)FDA LinkGeneric 01/2015
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2015
1	telaprevirIBA 01/2015
1	RivaroxabanIBA 01/2014
1	Meglumine AntimoniateIBA 03/2012
1	SteroidsIBA 01/2010
1	Promethazine (Promet)FDA LinkGeneric 01/2010

Therapy/Procedure

10	Therapeutics 11/2020 - 01/2012
2	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 01/2014
1	Induced Abortion (Induced Abortions) 01/2022
1	Chemoprevention 11/2020
1	Drug Therapy (Chemotherapy) 03/2015
1	Salvage Therapy 01/2014